Back to Curaleaf® or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g2/mg THCTrace CBD
0.05/g10/mg THCTrace CBD
0.1/g20/mg THCTrace CBD
0.15/g30/mg THCTrace CBD
0.2/g40/mg THCTrace CBD
0.25/g50/mg THCTrace CBD
0.3/g60/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United States Curaleaf®
Designation
T20
Cultivar/Strain
Lavender Cake
Classification
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
18-22%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Portugal Terra Verde
Cultivated in
Flag of Portugal Portugal
Irradiation
Gamma-Irradiated
Irradiated in
Flag of Spain Spain
Imported by
United Kingdom Curaleaf Laboratories
Imported as
Schedule I: Raw Material
Packaged in
Flag of United Kingdom United Kingdom
Packaged by
United Kingdom Curaleaf Laboratories

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Limited (Sapphire)

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

Further details to follow.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United States About Curaleaf Holdings Inc

Curaleaf® Logo

We are European leaders in production and research of medicinal cannabis. With our products and in-depth knowledge of cannabinoid therapies, we support medical professionals with individualised treatments for patients.

We are European leaders in the production and research of medicinal cannabis. With our products and in-depth knowledge of cannabinoid therapies, we support medical professionals in the individual treatment of people. Our mission: to ensure medical care, education within a professional framework and natural cultivation under the highest possible quality standards. Cannabis is one of the oldest medicinal plants in the world and can improve the quality of life for people with acute and chronic diseases.

We value sustainable cultivation and already ensure organic quality for numerous cannabis varieties. All of our production processes are certified according to GMP (Good Manufacturing Practice) standards. We commit ourselves to the strictest quality standards. Independent controls confirm: Our products in the area of ​​full-spectrum cannabis extracts and flowers are single-variety, of the highest quality and reliably available.

curaleafinternational.com/

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)